126 related articles for article (PubMed ID: 16924652)
1. Refractory thrombocytopenia and positive platelet crossmatches without HLA or platelet-specific antibodies.
Kankirawatana S; Huang ST; Arndt DW; Marques MB
Am J Hematol; 2007 Feb; 82(2):175-6. PubMed ID: 16924652
[No Abstract] [Full Text] [Related]
2. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.
Rubinstein P
Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628
[No Abstract] [Full Text] [Related]
3. Platelet replacement therapy: a clinical assessment.
Hester JP; McCredie KB; Freireich EJ
Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
[No Abstract] [Full Text] [Related]
4. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
[No Abstract] [Full Text] [Related]
5. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions.
Brooks EG; MacPherson BR; Fung MK
Transfusion; 2008 Oct; 48(10):2159-66. PubMed ID: 18631168
[TBL] [Abstract][Full Text] [Related]
6. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
[TBL] [Abstract][Full Text] [Related]
7. Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Vieira J; Aster RH
Transplant Proc; 1977 Mar; 9(1):519-21. PubMed ID: 867500
[No Abstract] [Full Text] [Related]
8. Management of patients refractory to platelet transfusion.
Chockalingam P; Sacher RA
J Infus Nurs; 2007; 30(4):220-5. PubMed ID: 17667077
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
10. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
[No Abstract] [Full Text] [Related]
11. [Clinical aspects of platelet transfusion].
Julia A; Massuet L; Pujol M; Martín Vega C
Sangre (Barc); 1985; 30(4-B):548-56. PubMed ID: 3909466
[No Abstract] [Full Text] [Related]
12. Platelet transfusion refractoriness.
Hod E; Schwartz J
Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
[TBL] [Abstract][Full Text] [Related]
13. [Serological typing of HLA].
Kuwata S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():738-44. PubMed ID: 16111384
[No Abstract] [Full Text] [Related]
14. Luminex donor-specific crossmatches.
Billen EV; Voorter CE; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2008 Jun; 71(6):507-13. PubMed ID: 18380779
[TBL] [Abstract][Full Text] [Related]
15. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
Bray RA; Hurley CK; Kamani NR; Woolfrey A; Müller C; Spellman S; Setterholm M; Confer DL
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):45-53. PubMed ID: 18721780
[No Abstract] [Full Text] [Related]
16. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.
Spellman S; Setterholm M; Maiers M; Noreen H; Oudshoorn M; Fernandez-Viña M; Petersdorf E; Bray R; Hartzman RJ; Ng J; Hurley CK
Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):37-44. PubMed ID: 18721779
[No Abstract] [Full Text] [Related]
17. Role of HLA in hematopoietic SCT.
Nowak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
[TBL] [Abstract][Full Text] [Related]
18. Strategies for new donor typing based on donor HLA type or donor characteristics.
Little AM; Jindra P; Raffoux C
Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153
[TBL] [Abstract][Full Text] [Related]
19. [Blood component transfusion therapy].
Takahashi K; Juji T
Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):897-901. PubMed ID: 1919204
[No Abstract] [Full Text] [Related]
20. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]